Compare ADMA Biologics Inc (ADMA) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? ADMA Biologics Inc trades at $9.26 (market cap $2.13B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.63. Which is the better fit depends on your goals.
| ADMA | VTIP | |
|---|---|---|
Market Cap | $2.13B | — |
Sector | Health | — |
52-Week High | $20.38 | $50.75 |
52-Week Low | $7.60 | $49.39 |
Enterprise Value | $2.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
VTIP (Vanguard Short-Term Inflation-Protected Securities ETF) trades at $49.64 with minimal daily movement (+0.12%). The technical picture shows conflicting signals with moving averages indicating bearish pressure while oscillators suggest potential oversold conditions. Recent news highlights VTIP's role as an inflation hedge, with multiple institutional investors increasing positions. The ETF focuses on short-term Treasury Inflation-Protected Securities, designed to protect against rising consumer prices.
VTIP offers investors exposure to inflation-protected government bonds with lower duration risk than longer-term TIPS funds. Current market conditions favor inflation-hedging assets, though the fund faces risks from potential Fed policy shifts and interest rate volatility. The ETF's structure provides built-in CPI adjustment, making it relevant in the current inflationary environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
